SCHEMBL12444359

SCHEMBL12444359

O=Cc1ccccc1C1OC(=O)CC1C(=O)O

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.40
ALDH1A1 P00352 5/20 0.39
KDM4E B2RXH2 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.38
USP2 O75604 1/20 0.36
TSHR P16473 1/20 0.36
KMT2A Q03164 2/20 0.36
HPGD P15428 1/20 0.35
HSD17B10 Q99714 1/20 0.35
MEN1 O00255 1/20 0.34
LMNA P02545 1/20 0.34
THRB P10828 1/20 0.34
BLM P54132 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
EDNRB P24530 1/20 0.34
EDNRA P25101 1/20 0.34
TRIM24 O15164 1/20 0.33
TRIM33 Q9UPN9 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12330011 0.79 GAA (0.45) GAAALDH1A1KDM4ESMN1; SMN2USP2
SCHEMBL19834324 0.79 KMT2A (0.42) GAAALDH1A1KDM4ESMN1; SMN2USP2
SCHEMBL2804266 0.76 GAA (0.61) GAAALDH1A1KDM4ESMN1; SMN2USP2
SCHEMBL6890626 0.75 TSHR (0.55) ALDH1A1USP2TSHRKMT2AHPGD
SCHEMBL6890624 0.75 TSHR (0.55) ALDH1A1USP2TSHRKMT2AHPGD
SCHEMBL28133180 0.75 RBP4 (0.44) GAAALDH1A1KDM4ESMN1; SMN2KMT2A
SCHEMBL6890628 0.75 TSHR (0.55) ALDH1A1USP2TSHRKMT2AHPGD
SCHEMBL6885972 0.75 TSHR (0.55) ALDH1A1USP2TSHRKMT2AHPGD
SCHEMBL19834337 0.72 TSHR (0.41) GAAALDH1A1KDM4ESMN1; SMN2USP2
SCHEMBL19834339 0.70 HTR1A (0.44) GAAALDH1A1USP2TSHRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110178112-A1 PPAR Modulators EVOLVA SA (CH) 2011-07-21 US disclosed
US-20110178112-A1 PPAR Modulators EVOLVA SA (CH) 2011-07-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110178112-A1 PPAR Modulators PPARD, PPARG, PPARA GAA 2923/4885ALDH1A1 1099/4885KDM4E 3443/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.